BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 7615745)

  • 1. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
    Gehrt A; Peter J; Pizzo PA; Walsh TJ
    J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.
    Espinel-Ingroff A; Dawson K; Pfaller M; Anaissie E; Breslin B; Dixon D; Fothergill A; Paetznick V; Peter J; Rinaldi M
    Antimicrob Agents Chemother; 1995 Feb; 39(2):314-9. PubMed ID: 7726488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs.
    Pfaller MA; Messer SA; Mills K; Bolmström A
    J Clin Microbiol; 2000 Sep; 38(9):3359-61. PubMed ID: 10970383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Mycopathologia; 1998; 141(2):73-7. PubMed ID: 9750338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
    Lass-Flörl C; Speth C; Kofler G; Dierch MP; Gunsilius E; Würzner R
    Int J Antimicrob Agents; 2003 Mar; 21(3):229-33. PubMed ID: 12636983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
    Espinel-Ingroff A; Bartlett M; Bowden R; Chin NX; Cooper C; Fothergill A; McGinnis MR; Menezes P; Messer SA; Nelson PW; Odds FC; Pasarell L; Peter J; Pfaller MA; Rex JH; Rinaldi MG; Shankland GS; Walsh TJ; Weitzman I
    J Clin Microbiol; 1997 Jan; 35(1):139-43. PubMed ID: 8968895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
    Johnson EM; Szekely A; Warnock DW
    J Antimicrob Chemother; 1998 Dec; 42(6):741-5. PubMed ID: 10052897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
    Pfaller MA; Marco F; Messer SA; Jones RN
    Diagn Microbiol Infect Dis; 1998 Apr; 30(4):251-5. PubMed ID: 9582584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Arikan S; Lozano-Chiu M; Paetznick V; Nangia S; Rex JH
    J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.
    Espinel-Ingroff A
    J Clin Microbiol; 1998 Jan; 36(1):198-202. PubMed ID: 9431946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
    Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
    Espinel-Ingroff A
    J Clin Microbiol; 1998 Oct; 36(10):2950-6. PubMed ID: 9738049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; del Valle O; Pemán J; Cantón E; Hernández-Molina JM; Santos P
    Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the semisolid agar antifungal susceptibility test with the NCCLS M38-P broth microdilution test for screening of filamentous fungi.
    Kuzucu C; Rapino B; McDermott L; Hadley S
    J Clin Microbiol; 2004 Mar; 42(3):1224-7. PubMed ID: 15004080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi.
    Pujol I; Guarro J; Llop C; Soler L; Fernández-Ballart J
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2106-10. PubMed ID: 8878589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.